{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:10:24Z","timestamp":1787879424433,"version":"build-2784847793"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T00:00:00Z","timestamp":1465516800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Chinese-Hungarian Scientific Cooperation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s40261-016-0415-x","type":"journal-article","created":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T22:24:08Z","timestamp":1465511048000},"page":"697-704","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial"],"prefix":"10.1007","volume":"36","author":[{"given":"Weiwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfei","family":"Nao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuenan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,10]]},"reference":[{"key":"415_CR1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40256-013-0007-6","volume":"13","author":"S Bansal","year":"2013","unstructured":"Bansal S, Sangha KS, Khatri P. Drug treatment of acute ischemic stroke. Am J Cardiovasc Drugs. 2013;13:57\u201369.","journal-title":"Am J Cardiovasc Drugs."},{"key":"415_CR2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1747-4949.2009.00237.x","volume":"4","author":"N Venketasubramanian","year":"2009","unstructured":"Venketasubramanian N, Chen CL, Gan RN, et al. A double-blind, placebo-controlled, randomized, multicenter study to investigate CHInese Medicine Neuroaid Efficacy on Stroke recovery (CHIMES study). Int J Stroke. 2009;4:54\u201360.","journal-title":"Int J Stroke."},{"key":"415_CR3","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/01.RVI.0000107490.61085.10","volume":"15","author":"PP Ng","year":"2004","unstructured":"Ng PP, Higashida RT, Cullen SP, et al. Intraarterial thrombolysis trials in acute ischemic stroke. J Vasc Interv Radiol. 2004;15:S77\u201385.","journal-title":"J Vasc Interv Radiol"},{"key":"415_CR4","first-page":"CD000480","volume":"1","author":"D Bereczki","year":"2008","unstructured":"Bereczki D, Fekete I. Vinpocetine for acute ischaemic stroke. Cochrane Database Syst Rev. 2008;1:CD000480.","journal-title":"Cochrane Database Syst Rev."},{"key":"415_CR5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1734-1140(11)70574-6","volume":"63","author":"S Patyar","year":"2011","unstructured":"Patyar S, Prakash A, Modi M, et al. Role of vinpocetine in cerebrovascular diseases. Pharmacol Rep. 2011;63:618\u201328.","journal-title":"Pharmacol Rep."},{"key":"415_CR6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bbrc.2013.03.092","volume":"434","author":"Y Cai","year":"2013","unstructured":"Cai Y, Li JD, Yan C. Vinpocetine attenuates lipid accumulation and atherosclerosis formation. Biochem Biophys Res Commun. 2013;434:439\u201343.","journal-title":"Biochem Biophys Res Commun."},{"key":"415_CR7","first-page":"376","volume":"43","author":"N Tamaki","year":"1985","unstructured":"Tamaki N, Matsumoto S. Agents to improve cerebrovascular circulation and cerebral metabolism\u2013vinpocetine. Nihon Rinsho. 1985;43:376\u20138.","journal-title":"Nihon Rinsho."},{"key":"415_CR8","first-page":"1984","volume":"26","author":"A Szobor","year":"1976","unstructured":"Szobor A, Klein M. Ethyl apovincaminate therapy in neurovascular diseases. Arzneimittelforschung. 1976;26:1984\u20139.","journal-title":"Arzneimittelforschung"},{"key":"415_CR9","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1556\/OH.2007.28115","volume":"148","author":"E Bagoly","year":"2007","unstructured":"Bagoly E, Feh\u00e9r G, Szap\u00e1ry L. The role of vinpocetine in the treatment of cerebrovascular diseases based in human studies. Orv Hetil. 2007;148:1353\u20138.","journal-title":"Orv Hetil"},{"key":"415_CR10","first-page":"56","volume":"92","author":"EM Burtsev","year":"1992","unstructured":"Burtsev EM, Savkov VS, Shprakh VV, et al. 10-year experience with using Cavinton in cerebrovascular disorders. Zh Nevropatol Psikhiatr Im S S Korsakova. 1992;92:56\u201360.","journal-title":"Zh Nevropatol Psikhiatr Im S S Korsakova"},{"key":"415_CR11","first-page":"973","volume":"144","author":"L Szap\u00e1ry","year":"2003","unstructured":"Szap\u00e1ry L, Horv\u00e1th B, Alexy T, et al. Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease. Orv Hetil. 2003;144:973\u20138.","journal-title":"Orv Hetil"},{"key":"415_CR12","first-page":"20","volume":"112","author":"GR Tabeeva","year":"2012","unstructured":"Tabeeva GR. Azimova IuE. The multimodal strategy for the neuroprotection in stroke: results of the Russian multicenter clinical-epidemiological program SOKOL [in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112:20\u201330.","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"415_CR13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1468-1331.2001.00181.x","volume":"8","author":"VL Feigin","year":"2001","unstructured":"Feigin VL, Doronin BM, Popova TF, et al. Vinpocetine treatment in acute ischaemic stroke: a pilot single-blind randomized clinical trial. Eur J Neurol. 2001;8:81\u20135.","journal-title":"Eur J Neurol"},{"key":"415_CR14","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.01.020","volume":"23","author":"K Overgaard","year":"2014","unstructured":"Overgaard K. The effects of citicoline on acute ischemic stroke: a review. J Stroke Cerebrovasc Dis. 2014;23:1764\u20139.","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"415_CR15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1517\/14656560902765652","volume":"10","author":"WM Clark","year":"2009","unstructured":"Clark WM. Efficacy of citicoline as an acute stroke treatment. Expert Opin Pharmacother. 2009;10:839\u201346.","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"415_CR16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s11596-016-1579-6","volume":"36","author":"PY Shi","year":"2016","unstructured":"Shi PY, Zhou XC, Yin XX, et al. Early application of citicoline in the treatment of acute stroke: a meta-analysis of randomized controlled trials. J Huazhong Univ Sci Technolog Med Sci. 2016;36(2):270\u20137.","journal-title":"J Huazhong Univ Sci Technolog Med Sci."},{"key":"415_CR17","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s40261-013-0121-x","volume":"33","author":"Y Zhu","year":"2013","unstructured":"Zhu Y, Zhang G, Zhao J, et al. Efficacy and safety of mildronate for acute ischemic stroke: a randomized, double-blind, active-controlled phase II multicenter trial. Clin Drug Investig. 2013;33:755\u201360.","journal-title":"Clin Drug Investig"},{"key":"415_CR18","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1161\/01.STR.30.8.1538","volume":"30","author":"G Sulter","year":"1999","unstructured":"Sulter G, Steen C, De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke. 1999;30:1538\u201341.","journal-title":"Stroke"},{"key":"415_CR19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(12)60813-7","volume":"380","author":"A D\u00e1valos","year":"2012","unstructured":"D\u00e1valos A, Alvarez-Sab\u00edn J, Castillo J, et al. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet. 2012;380:349\u201357.","journal-title":"Lancet"},{"key":"415_CR20","first-page":"36","volume":"60","author":"M Mitta","year":"2012","unstructured":"Mitta M, Goel D, Bansal KK, et al. Edaravone\u2014citicoline comparative study in acute ischemic stroke (ECCS-AIS). J Assoc Physicians India. 2012;60:36\u20138.","journal-title":"J Assoc Physicians India"},{"key":"415_CR21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1471-4159.2012.07891.x","volume":"123","author":"A Bustamante","year":"2012","unstructured":"Bustamante A, Giralt D, Garcia-Bonilla L, et al. Citicoline in pre-clinical animal models of stroke: a meta-analysis shows the optimal neuroprotective profile and the missing steps for jumping into a stroke clinical trial. J Neurochem. 2012;123:217\u201325.","journal-title":"J Neurochem"},{"key":"415_CR22","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1161\/01.STR.0000038691.03334.71","volume":"33","author":"A D\u00e1valos","year":"2002","unstructured":"D\u00e1valos A, Castillo J, Alvarez-Sab\u00edn J, et al. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke. 2002;33:2850\u20137.","journal-title":"Stroke"},{"key":"415_CR23","first-page":"333","volume":"24","author":"Q Wang","year":"2014","unstructured":"Wang Q, Ye H, Su Y. Transcranial Doppler sonography monitors cerebral blood flow of mannitol-treated patients with acute large hemispheric infarction. Turk Neurosurg. 2014;24:333\u20136.","journal-title":"Turk Neurosurg."},{"key":"415_CR24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1272\/jnms.79.104","volume":"79","author":"K Katsura","year":"2012","unstructured":"Katsura K, Suda S, Abe A, et al. Brain protection therapy in acute cerebral infarction. J Nippon Med Sch. 2012;79:104\u201310.","journal-title":"J Nippon Med Sch."},{"key":"415_CR25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000338247","volume":"69","author":"SW Han","year":"2013","unstructured":"Han SW, Lee SS, Kim SH, et al. Effect of cilostazol in acute lacunar infarction based on pulsatility index of transcranial Doppler (ECLIPse): a multicenter, randomized, double-blind, placebo-controlled trial. Eur Neurol. 2013;69:33\u201340.","journal-title":"Eur Neurol"},{"key":"415_CR26","unstructured":"Shanghai Rxmidas Pharmaceuticals Co. Ltd. Chinese Assessment for Vinpocetine in Neurology (CAVIN) [ClinicalTrials.gov identifier NCT01400035]. US National Institutes of Health, ClinicalTrials.gov. Accessed 20 May 2016."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-016-0415-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-016-0415-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-016-0415-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:04:25Z","timestamp":1498305865000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-016-0415-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,10]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["415"],"URL":"https:\/\/doi.org\/10.1007\/s40261-016-0415-x","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,10]]}}}